2021 CMSC Annual Meeting

Tag: MI

Poster-Quality of Life and Outcomes

Characterizing Activities of Daily Living in MS Patients with Processing Speed Scores Above and below a Threshold Previously Shown to Predict Employment Status

Background: Cognitive impairment can occur early in the course of multiple sclerosis (MS) and worsen progressively over time, impacting...

Read More

Poster-Rehabilitation Poster

Validation and Minimal Detectable Change of the Walking While Talking Test As a Measure of Dual-Task Performance in Ambulatory Individuals with Multiple Sclerosis

Background: Multiple Sclerosis (MS) is a progressive neurodegenerative disease associated with demyelination of the central nervous system...

Read More

Poster-Quality of Life and Outcomes

Coping Moderates the Association between Symptoms and Functional and Affective Outcomes in the Daily Lives of Individuals with Multiple Sclerosis

Background: Pain and fatigue are highly prevalent in multiple sclerosis (MS) and are associated with adverse outcomes spanning the...

Read More

Poster-Quality of Life and Outcomes

Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes

Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...

Read More

Poster-Neurophysiology; Neuropsychology and Neuropsychiatry

Examining the Influence of Processing Speed on the Relation between Backward Walking and Falls in Persons with Multiple Sclerosis

Background: Backward walking (BW) is a complex motor task that requires increased cognitive demands. In persons with multiple sclerosis...

Read More

Poster-Disease-modifying Therapy

A Single Center Retrospective Analysis of Insurance Policy Impact on the Choice of Multiple Sclerosis Disease Modifying Therapies

Background: Financial barriers to disease modifying therapies (DMT) for multiple sclerosis (MS) have been widely reported; yet the impact...

Read More

Platform-Disease Management

Treating Minority Patients with Multiple Sclerosis: Development of the CHIMES Trial

Background: Black, African American (AA) and Hispanic/Latino (HA) patients with multiple sclerosis (MS) have greater disease severity and...

Read More